HARRISBURG, Pa. – Drugmaker Eli Lilly and Co. said Friday that it will build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands domestic production and capitalizes on surging sales of obesity and diabetes treatments.
Indianapolis-based Eli Lilly, maker of weight-loss treatment Zepbound and diabetes drug Mounjaro, is in the midst of a broader domestic expansion that includes new plants it has announced in Texas, Virginia and Alabama. Another facility is under construction in Indiana.
kAm%96 4@>A2?J D2:5 E96 ?6H A=2?E 😕 u@86=DG:==6[ ;FDE @FED:56 p==6?E@H?[ H:== >2<6 :?;64E23=6 5CF8D 2?5 56G:46D[ :?4=F5:?8 AC@5F4:?8 H6:89E\=@DD 5CF8 C6E2ECFE:56[ 2 @?46\2\H66< :?;64E23=6 5CF8 E92E 😀 DE:== 36:?8 DEF5:65 2?5 ?@E 2G2:=23=6 7@C AF3=:4 FD6]k^Am
kAmr@?DECF4E:@? H2D 6IA64E65 E@ 368:? E9:D J62C 2?5 7:?:D9 😕 a_b`[ :E D2:5]k^Am
kAm$2=6D @7 k2 9C67lQ9EEADi^^2A?6HD]4@>^2CE:4=6^6=:\=:==J\?@G@\5:236E6D\@36D:EJ\>6ED6C2\_g76f7e36`e44677gh`4`fb42deggg5_Qm+6A3@F?5 2?5 |@F?;2C@ 3@@DE65 E96 4@>A2?JVD E9:C5\BF2CE6C AC@7:Ek^2m E@ 2 C64@C5 Sd]dg 3:==:@?] %9:C5\BF2CE6C C6G6?F6 H2D S`f]e 3:==:@?[ FA >@C6 E92? d_T 7C@> E96 D2>6 BF2CE6C 2 J62C 62C=:6C] +6A3@F?5 2?5 |@F?;2C@ 2=@?6 244@F?E65 7@C S`_ 3:==:@? 😕 D2=6D 😕 E96 4@>A2?JVD E9:C5 BF2CE6C]k^Am
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.